Pyridine → HCID 22010636, 화합물
반응식
[CH3:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:9]([C:14]([NH:16][C:17]3[CH:37]=[CH:36][C:20]([C:21]([N:23]([CH3:35])[C:24]4[CH:29]=[CH:28][CH:27]=[CH:26][C:25]=4[O:30][CH2:31][CH2:32][CH2:33][OH:34])=[O:22])=[CH:19][CH:18]=3)=[O:15])=[CH:10][CH:11]=[CH:12][CH:13]=2)=[CH:4][CH:3]=1.[N:38]1[CH:43]=[CH:42]C=[CH:40][CH:39]=1.Cl[C:45](OC1C=CC([N+]([O-])=O)=CC=1)=[O:46].[CH3:57][N:58]1CCNCC1>ClCCl>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[C:9]([C:14]([NH:16][C:17]3[CH:18]=[CH:19][C:20]([C:21]([N:23]([CH3:35])[C:24]4[CH:29]=[CH:28][CH:27]=[CH:26][C:25]=4[O:30][CH2:31][CH2:32][CH2:33][O:34][C:45]([N:38]4[CH2:39][CH2:40][N:58]([CH3:57])[CH2:42][CH2:43]4)=[O:46])=[O:22])=[CH:36][CH:37]=3)=[O:15])=[CH:10][CH:11]=[CH:12][CH:13]=2)=[CH:6][CH:7]=1참가 물질
실험 절차
A solution of 4-(4′-methylbiphenyl-2-carboxamido)-N-methyl-N-[2-(3-hydroxypropoxy)phenyl]benzamide (300 mg) in dichloromethane (15 ml) was treated with pyridine (95.8 mg) and p-nitrophenyl chloroformate (183 mg). After 4.5 hours, 1-methylpiperazine (303 mg) was added to the reaction mixture and stirred for a further 1 hour at ambient temperature. After concentration, the residue was dissolved in ethyl acetate and washed with saturated sodium hydrogen carbonate solution and brine, dried over sodium sulfate, concentrated, and purified by silica gel column chromatography (SiO2; 30 g, 3% methanol in dichloromethane) to give 4-(4′-methylbiphenyl-2-carboxamido)-N-methyl-N-[2-[3-(4-methylpiperazin-1-carbonyloxy)propoxy]phenyl]benzamide (200 mg) as white amorphous.
후처리
- concentrationAfter concentration
- dissolutionthe residue was dissolved in ethyl acetate
- washwashed with saturated sodium hydrogen carbonate solution and brine
- dry with materialdried over sodium sulfate
- concentrationconcentrated
- custompurified by silica gel column chromatography (SiO2; 30 g, 3% methanol in dichloromethane)
출처 및 근거
- ORD 기록
- ord-0cb9e8ba924b448686f85f3acd3001bf
- 출처 데이터셋
- uspto-grants-2001_04
- 특허 번호
- US06211242B1
반응 노트
불러오는 중…